In a recent interview, Former President of the Brazilian Health Surveillance Agency (Anvisa), Gonzalo Vecina Neto, stated that although e-cigarette products are "harmful to health," he believes that monitoring them would be far better than the current illegal trade situation. He also mentioned that this decision is expected to take some time.
Wechiner served as the first chairman of Anvisa from 1999 to 2003. In 2009, the organization prohibited e-cigarettes. In 2022, the ban remains in place, but the topic continues to be debated within the institution.
The current president of Anvisa, Antonio Barra Torres, has stated his intent to initiate a public consultation on this matter.
Weiner voiced his opposition to the use of e-cigarettes, but stated that he believes regulating consumption is a better approach than the current situation of illegal trade in the country.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
